天津赛尔生物技术有限公司成立于2004年,是从事抗体及相关产品研发与生物技术服务的“国家高新技术产业”,座落于天津滨海新区。我们秉承“品质至上,追求卓越”理念不断发展壮大,经过十余年的发展,赛尔生物已经拥有一个多学科跨专业的优秀专业人员团队,多名技术骨干均具有在海外著名科研机构学习工作的经历。现拥有研发楼和动物实验楼,具有市场优势产品研发技术体系,以及符合行业规律、以人为本并与国际接轨的高效运行管理摸式。我们专注于两大领域,服务于海外内市场。
天津赛尔生物专注抗体(单抗、多抗)研发,建立了一套标准化的抗体生产体系,每种抗体产品的生产均严格按照操作规程完成,抗体应用于Westernblot(WB),IHC等方法检测细胞内源性蛋白作质控标准,以保证抗体的产品质量。凡是购买我公司抗体,并于2018年1月1日以后发表文章,且文章中明确标注其使用产品来源于天津赛尔生物的,可领取相应奖励。
奖励规则如下:
中文文章:50 μl抗体2支+鼠标垫1个
SCI期刊杂志:
0<IF<5 :100 μl抗体2支+鼠标垫1个
5≤IF<10:200 μl抗体2支+鼠标垫1个
10≤IF<20:200 μl抗体3支+鼠标垫1个
20≤IF :200 μl抗体5支+鼠标垫1个
备注: 1. 每篇文章限参与活动一次。
2. 需提供文章全文。
公司产品发表SCI论文部分如下
LiuJ,YangC,GuY,etal.KnockdownofthelncRNASNHG8inhibitscellgrowthinEpstein-Barrvirus-associatedgastriccarcinoma[J].Cellular&molecularbiologyletters,2018,23(1):17.
AishanjiangA,RouziN,JiaoZ,etal.MicroRNA-9enhancesinvasionandmigrationofcervicalcarcinomasbydirectlytargetingFOXO1[J].Europeanreviewformedicalandpharmacologicalsciences,2018,22(8):2253-2260.
YuM,WangK,ZhangH,etal.DOTAP-IncorporatedPEG-PLGANanoparticlesforEfficientInVitroandInVivoGeneDelivery[J].JournalofBiomedicalNanotechnology,2018,14(2):281-293.
GaoP,LiC,ChangZ,etal.Carcinomaassociatedfibroblastsderivedfromoralsquamouscellcarcinomapromotelymphangiogenesisviac-Met/PI3K/AKTinvitro[J].OncologyLetters,2018,15(1):331-337.
LiH,WangY,SongY.MicroRNA-26binhibitstheimmuneresponsetoMycobacteriumtuberculosis(M.tb)infectioninTHP-1cellsviatargetingTGFbeta-activatedkinase-1(TAK1),apromoteroftheNF-kappaBpathway[J].INTERNATIONALJOURNALOFCLINICALANDEXPERIMENTALPATHOLOGY,2018,11(3):1218-1227.
WangY,FuD,ChenY,etal.G3BP1promotestumorprogressionandmetastasisthroughIL-6/G3BP1/STAT3signalingaxisinrenalcellcarcinomas[J].Celldeath&disease,2018,9(5):501.
ZhaoL,ZhouC,LiL,etal.AcupunctureimprovescerebralmicroenvironmentinmicewithAlzheimer’sdiseasetreatedwithhippocampalneuralstemcells[J].Molecularneurobiology,2017,54(7):5120-5130.
JiangC,GongF.MiR‐148apromotesmyocardialdifferentiationofhumanbonemesenchymalstromalcellsviaDNAmethyltransferase1(DNMT1)[J].Cellbiologyinternational,2017.
YangD,YangQ,WeiX,etal.TheroleofmiR-190a-5pcontributestodiabeticneuropathicpainviatargetingSLC17A6[J].Journalofpainresearch,2017,10:2395.
BuY,ZhengD,WangL,etal.LncRNATSIXpromotesosteoblastapoptosisinparticle-inducedosteolysisbydown-regulatingmiR-30a-5p[J].Connectivetissueresearch,2017:1-8.
LuWQ,HuYY,LinXP,etal.KnockdownofPKM2andGLS1expressioncansignificantlyreverseoxaliplatin-resistanceincolorectalcancercells[J].Oncotarget,2017,8(27):44171.
WangH,JiangZ,ChenH,etal.MicroRNA-495inhibitsgastriccancercellmigrationandinvasionpossiblyviatargetinghighmobilitygroupAT-hook2(HMGA2)[J].Medicalsciencemonitor:internationalmedicaljournalofexperimentalandclinicalresearch,2017,23:640.
YangX,HuY,LiuY,etal.C14orf28downregulatedbymiR-519dcontributestooncogenicityandregulatesapoptosisandEMTincolorectalcancer[J].Molecularandcellularbiochemistry,2017,434(1-2):197-208.
WangY,ZhangR,ZhangJ,etal.MicroRNA‐326‐3pameliorateshighglucoseandox‐LDL‐IC‐inducedfibroticinjuryinrenalmesangialcellsbytargetingFcγRIII[J].Nephrology,2017.
WangL,WangQT,LiuYP,etal.ATMSignalingPathwayIsImplicatedintheSMYD3-mediatedProliferationandMigrationofGastricCancerCells[J].Journalofgastriccancer,2017,17(4):295-305.
DingZ,ShenX,LiY.AssociationofnNOSandRho‑kinasewithage‑associatederectiledysfunctioninSprague‑Dawleyrats[J].Experimentalandtherapeuticmedicine,2017,13(3):1133-1136.
LiJ,LiuB,XueH,etal.MiR-217hasabilityastheusefuldiagnosticbioMarkerandregulateshumanpodocytecellsapoptosisviatargetingTNFSF11inmembranousnephropathy[J].
LiJ,LiuB,XueH,etal.miR-217IsaUsefulDiagnosticBiomarkerandRegulatesHumanPodocyteCellsApoptosisviaTargetingTNFSF11inMembranousNephropathy[J].BioMedResearchInternational,2017,2017.
YangX,LiH,SunH,etal.HepatitisBvirus-encodedmicroRNAcontrolsviralreplication[J].Journalofvirology,2017,91(10):e01919-16.
ChenJ,HongtingL,ShaopingL,etal.MiR-34-aactsasasuppressorinneuroblastomaprogressionbytargetingCD44[J].JPMA.TheJournalofthePakistanMedicalAssociation,2017,67(10):1524-1531.
ZhaoF,ZhengYF,ZengT,etal.PhosphorylationofSPOROCYTELESS/NOZZLEbytheMPK3/6kinaseisrequiredforantherdevelopment[J].Plantphysiology,2017:pp.01765.2016.
YangY,XieY,WuM,etal.Expressionofmmu-miR-96intheendometriumduringearlypregnancyanditsregulatoryeffectsonstromalcellapoptosisviaBcl2[J].Molecularmedicinereports,2017,15(4):1547-1554.
ZhuY,ZhangY,SuiZ,etal.USP14de-ubiquitinatesvimentinandmiR-320amodulatesUSP14andvimentintocontributetomalignancyingastriccancercells[J].Oncotarget,2017,8(30):48725.
ZhaoX,HuangL,XuW,etal.PhysapubescinBinhibitstumorgenesisandcircumventstaxolresistanceofovariancancercellsthroughSTAT3signaling[J].Oncotarget,2017,8(41):70130.
ZhaoX,HuangL,XuW,etal.PhysapubescinBinhibitstumorgenesisandcircumventstaxolresistanceofovariancancercellsthroughSTAT3signaling[J].Oncotarget,2017,8(41):70130.
LiuQ,GuoX,QueS,etal.LncRNARSU1P2contributestotumorigenesisbyactingasaceRNAagainstlet-7aincervicalcancercells[J].Oncotarget,2017,8(27):43768-43781.
CuiXB,PengH,LiRR,etal.MicroRNA-34afunctionsasatumorsuppressorbydirectlytargetingoncogenicPLCE1inKazakhesophagealsquamouscellcarcinoma[J].Oncotarget,2017,8(54):92454.